1
EXHIBIT 11
NOVAMETRIX MEDICAL SYSTEMS INC.
STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS
QUARTER ENDED SIX MONTHS ENDED
10-27-96 10-29-95 10-27-96 10-29-95
-------- -------- -------- --------
PRIMARY EARNINGS PER SHARE:
Weighted average number of shares of 6,955,902 5,877,547 6,809,614 5,864,584
Common Stock outstanding
Net effect of dilutive common stock
equivalents (1) 1,197,477 2,048,676 1,171,142 2,140,366
Total weighted average number of shares
of Common Stock and dilutive common ---------- ---------- ---------- ----------
stock equivalents outstanding 8,153,379 7,926,223 7,980,756 8,004,736
========== ========== ========== ==========
FULLY DILUTED EARNINGS PER SHARE:
Weighted average number of shares of 6,955,902 5,877,547 6,809,614 5,864,584
Common Stock outstanding
Net effect of dilutive common stock
equivalents (1) 1,403,505 2,048,676 1,518,532 2,140,152
Total weighted average number of shares
of Common Stock and dilutive common ---------- ---------- ---------- ----------
stock equivalents outstanding 8,359,407 7,926,223 8,328,146 8,004,736
========== ========== ========== ==========
Net income $ 696,158 $ 456,964 $1,344,032 $ 845,131
PER COMMON SHARE AMOUNTS:
Primary $ .09 $ .06 $ .17 $ .11
========== ========== ========== ==========
Fully Diluted $ .08 $ .06 $ .16 $ .11
========== ========== ========== ==========
(1) Common stock equivalents consist of the Company's Preferred Stock, stock
options, warrants and shares subscribed under the Company's Employee Stock
Purchase Plan. The computation of dilutive common stock equivalents is based on
the if-converted method for the Preferred Stock and on the treasury stock method
for the other common stock equivalents using the average market price for the
primary earnings per share computations and the higher of average or period-end
market price for the fully diluted earnings per share computations.
Page 16 of 17